Spots Global Cancer Trial Database for immunosuppression
Every month we try and update this database with for immunosuppression cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| RFA Plus Carrizumab vs Carrizumab Alone for HCC | NCT04150744 | Tumor Immunity Immunosuppressi... Radiofrequency ... | radiofrequency ... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma | NCT00300521 | Hepatocellular ... Liver Transplan... | ADV-TK (adenovi... | 0 Years - | Beijing Chao Yang Hospital | |
| ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals | NCT05655546 | Immunodeficienc... Immunosuppressi... HIV Infections Graft Versus Ho... Leukemia Lymphoma Cancer Multiple Myelom... Transplant Age-Related Imm... | Access to Cue H... | 18 Years - 120 Years | Scripps Translational Science Institute | |
| Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study | NCT00116090 | Uveitis Cancer Infection Mortality Immunosuppressi... | - | National Institutes of Health Clinical Center (CC) | ||
| Sunbit UV Measuring Device to Track Sun Behavior | NCT02221843 | Immunosuppressi... Skin Neoplasms | 50 Years - | University of Zurich | ||
| Cologne Cohort of Neutropenic Patients (CoCoNut) | NCT01821456 | Hematological M... Cancer Chemotherapy Neutropenia Immunosuppressi... | Antiinfectives | 1 Year - | University Hospital of Cologne | |
| Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses | NCT00175643 | Actinic Keratos... | imiquimod | 18 Years - 75 Years | University of British Columbia | |
| Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies | NCT06024538 | Lung Neoplasm Cancer Associat... Myeloid-Derived... | Tumor samples | 18 Years - | University Hospital, Bordeaux | |
| INvestigational Study Into Transplantation of the Uterus | NCT04244409 | Mayer-Rokitansk... Asherson's Synd... Postpartum Hemo... Cervical Cancer | 24 Years - 38 Years | Womb Transplant UK | ||
| Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies | NCT06024538 | Lung Neoplasm Cancer Associat... Myeloid-Derived... | Tumor samples | 18 Years - | University Hospital, Bordeaux | |
| RFA Plus Carrizumab vs Carrizumab Alone for HCC | NCT04150744 | Tumor Immunity Immunosuppressi... Radiofrequency ... | radiofrequency ... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Malignancies in Transplanted Patients | NCT02241564 | Neoplasms | Referral to a m... Switch from cal... | 18 Years - | Uppsala University | |
| Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer | NCT05810792 | Pancreatic Canc... Surgery Metastasis Immunosuppressi... | Histamine Dihyd... Interleukin-2 (... | 18 Years - | Sahlgrenska University Hospital, Sweden | |
| TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis | NCT00001862 | Juvenile Rheuma... Uveitis | Enbrel | - | National Institutes of Health Clinical Center (CC) | |
| ORCHARD- Optimising Home Assessment of Rural Patients | NCT05732922 | Organ Transplan... Cancer Inborn Errors o... Immunosuppressi... COPD Asthma Sickle Cell Dis... | A sphygmanomete... | 18 Years - 100 Years | University of Aberdeen | |
| Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study | NCT00116090 | Uveitis Cancer Infection Mortality Immunosuppressi... | - | National Institutes of Health Clinical Center (CC) | ||
| Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses | NCT00175643 | Actinic Keratos... | imiquimod | 18 Years - 75 Years | University of British Columbia | |
| Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies | NCT05148806 | Solid Organ Tra... Autoimmune Dise... Haematological ... | self-administer... | 12 Years - | Imperial College London | |
| Controling Intestinal Colonization With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae ESBL-E | NCT01931592 | Cancer | ESBL eradicatio... Placebo ESBL er... | 18 Years - | University of Cologne | |
| An Immunonutritional Approach to the Prevention of Skin Cancer | NCT01032343 | Skin Cancer | Omega-3 PUFA Gelatine | 18 Years - | University of Manchester | |
| Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC | NCT06024226 | Lung Neoplasms Myeloid-Derived... Immunosuppressi... | Tumor samples | 18 Years - | University Hospital, Bordeaux | |
| EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients | NCT01942005 | Immunosuppressi... Neoplasm | 18 Years - | University Hospital, Basel, Switzerland | ||
| Malignancies in Transplanted Patients | NCT02241564 | Neoplasms | Referral to a m... Switch from cal... | 18 Years - | Uppsala University | |
| Investigation of Immune Modulation by Modern Acupuncture in Gastroenterologic Cancers | NCT04692454 | Hepatocellular ... Gastrointestina... Immunosuppressi... | Modern acupunct... | 20 Years - 75 Years | Taipei Medical University WanFang Hospital | |
| Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas | NCT01030900 | Hodgkin Lymphom... Diffuse Large B... | Campath Rituximab EPOCH | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome | NCT00217594 | Myelodysplastic... | Alemtuzumab (Ca... | 18 Years - 72 Years | National Institutes of Health Clinical Center (CC) | |
| Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas | NCT01786018 | B-cell Lymphoma... | Thiotepa Busulfan Fludarabin transplant (HCT... Cytoreduction Immunosuppressi... Cyclosporine Methotrexate ATG Collection and ... | 18 Years - 65 Years | Azienda Ospedaliera San Giovanni Battista | |
| Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer | NCT05810792 | Pancreatic Canc... Surgery Metastasis Immunosuppressi... | Histamine Dihyd... Interleukin-2 (... | 18 Years - | Sahlgrenska University Hospital, Sweden | |
| Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases | NCT04834089 | Immunosuppressi... Cancer COVID-19 Other Complicat... Chemotherapy Renal Disease Diabetes Mellit... Cardiovascular ... Chronic Obstruc... | AntiSARS-CoV-2 ... Placebo | 18 Years - | Butantan Institute | |
| Sunbit UV Measuring Device to Track Sun Behavior | NCT02221843 | Immunosuppressi... Skin Neoplasms | 50 Years - | University of Zurich | ||
| Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study | NCT01423708 | Liver Failure Liver Diseases Liver Cirrhosis Liver Neoplasms | Everolimus | 18 Years - 70 Years | Azienda Ospedaliera di Padova | |
| MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer | NCT00374049 | Prostate Cancer | MUC_1 | 18 Years - | University of Pittsburgh | |
| An Immunonutritional Approach to the Prevention of Skin Cancer | NCT01032343 | Skin Cancer | Omega-3 PUFA Gelatine | 18 Years - | University of Manchester | |
| Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia | NCT00005937 | Myelodysplastic... | Antithymocyte g... Cyclosporine | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| ORCHARD- Optimising Home Assessment of Rural Patients | NCT05732922 | Organ Transplan... Cancer Inborn Errors o... Immunosuppressi... COPD Asthma Sickle Cell Dis... | A sphygmanomete... | 18 Years - 100 Years | University of Aberdeen | |
| Investigation of Immune Modulation by Modern Acupuncture in Gastroenterologic Cancers | NCT04692454 | Hepatocellular ... Gastrointestina... Immunosuppressi... | Modern acupunct... | 20 Years - 75 Years | Taipei Medical University WanFang Hospital | |
| Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies | NCT02556931 | Myelodysplastic... Chronic Myelomo... Small Lymphocyt... Chronic Lymphoc... Prolymphocytic ... Chronic Myeloid... Chronic Myelopr... Multiple Myelom... Plasma Cell Neo... Plasma Cell Dys... Myelofibrosis Polycythemia Ve... Essential Throm... Plasma Cell Leu... | Fludarabine Cyclophosphamid... Total body irra... Tacrolimus Mycophenolate m... | - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids | NCT01137084 | Immunosuppressi... Hepatocellular ... Liver Transplan... Post-operative ... | solu medrol a steroid-free ... | - | Shanghai Jiao Tong University School of Medicine | |
| Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases | NCT04834089 | Immunosuppressi... Cancer COVID-19 Other Complicat... Chemotherapy Renal Disease Diabetes Mellit... Cardiovascular ... Chronic Obstruc... | AntiSARS-CoV-2 ... Placebo | 18 Years - | Butantan Institute | |
| Controling Intestinal Colonization With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae ESBL-E | NCT01931592 | Cancer | ESBL eradicatio... Placebo ESBL er... | 18 Years - | University of Cologne | |
| A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors | NCT06188208 | Advanced Solid ... Advanced Hemato... | VVD-130850 Pembrolizumab | 18 Years - | Vividion Therapeutics, Inc. | |
| Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies | NCT06024538 | Lung Neoplasm Cancer Associat... Myeloid-Derived... | Tumor samples | 18 Years - | University Hospital, Bordeaux | |
| Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study | NCT01423708 | Liver Failure Liver Diseases Liver Cirrhosis Liver Neoplasms | Everolimus | 18 Years - 70 Years | Azienda Ospedaliera di Padova | |
| Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study | NCT01423708 | Liver Failure Liver Diseases Liver Cirrhosis Liver Neoplasms | Everolimus | 18 Years - 70 Years | Azienda Ospedaliera di Padova | |
| MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer | NCT00374049 | Prostate Cancer | MUC_1 | 18 Years - | University of Pittsburgh | |
| A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS) | NCT00072969 | Myelodysplastic... | Daclizumab | - | National Institutes of Health Clinical Center (CC) | |
| ORCHARD- Optimising Home Assessment of Rural Patients | NCT05732922 | Organ Transplan... Cancer Inborn Errors o... Immunosuppressi... COPD Asthma Sickle Cell Dis... | A sphygmanomete... | 18 Years - 100 Years | University of Aberdeen | |
| Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient | NCT03806764 | Cytomegalovirus... Haematological ... Organ or Tissue... Immune Suppress... | Blood sampling | 18 Years - | Melbourne Health | |
| Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies | NCT05148806 | Solid Organ Tra... Autoimmune Dise... Haematological ... | self-administer... | 12 Years - | Imperial College London |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
